Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations?

Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study Carlos Lorenzo , MD 1 , Manel...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 24; no. 12; pp. 2059 - 2064
Main Authors Carlos Lorenzo, Manel Serrano-Rios, Maria T. Martinez-Larrad, Rafael Gabriel, Ken Williams, Clicerio Gonzalez-Villalpando, Michel P. Stern, Helen P. Hazuda, Steven M. Haffner
Format Journal Article
LanguageEnglish
Published American Diabetes Association 01.12.2001
Online AccessGet full text

Cover

Loading…
Abstract Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study Carlos Lorenzo , MD 1 , Manel Serrano-Rios , MD 2 , Maria T. Martinez-Larrad , MD 2 , Rafael Gabriel , MD 3 , Ken Williams , MS 1 , Clicerio Gonzalez-Villalpando , MD 4 , Michel P. Stern , MD 1 , Helen P. Hazuda , PHD 1 and Steven M. Haffner , MD 1 1 Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 2 Department of Internal Medicine, Hospital Universitario de San Carlos, Madrid, Spain 3 Department of Internal Medicine, Hospital de La Princesa, Madrid, Spain 4 Center of Studies in Diabetes, American British Cowdray Hospital, Mexico City, Mexico Abstract OBJECTIVE —Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related, in part, not to Native American genetic admixture but to Spanish genetic admixture. RESEARCH DESIGN AND METHODS —Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose ≥7.0 mmol/l or 2-h glucose ≥11.1 mmol/l or use of antidiabetic agents. RESULTS —A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain (6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip ratio. CONCLUSIONS —The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations. MCDS, Mexico City Diabetes Study OR, odds ratio SAHS, San Antonio Heart Study SA-NHW, non-Hispanic whites in San Antonio SA-MA, Mexican-Americans in San Antonio SIRS, Spanish Insulin Resistance Study WHR, waist-to-hip ratio Footnotes Address correspondence and reprint requests to Carlos Lorenzo, MD, Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873. E-mail: lorenzo{at}uthscsa.edu . Received for publication 4 May 2001 and accepted in revised form 4 September 2001. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
AbstractList OBJECTIVE—Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related, in part, not to Native American genetic admixture but to Spanish genetic admixture. RESEARCH DESIGN AND METHODS—Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose ≥7.0 mmol/l or 2-h glucose ≥11.1 mmol/l or use of antidiabetic agents. RESULTS—A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain (6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip ratio. CONCLUSIONS—The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations.
Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study Carlos Lorenzo , MD 1 , Manel Serrano-Rios , MD 2 , Maria T. Martinez-Larrad , MD 2 , Rafael Gabriel , MD 3 , Ken Williams , MS 1 , Clicerio Gonzalez-Villalpando , MD 4 , Michel P. Stern , MD 1 , Helen P. Hazuda , PHD 1 and Steven M. Haffner , MD 1 1 Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 2 Department of Internal Medicine, Hospital Universitario de San Carlos, Madrid, Spain 3 Department of Internal Medicine, Hospital de La Princesa, Madrid, Spain 4 Center of Studies in Diabetes, American British Cowdray Hospital, Mexico City, Mexico Abstract OBJECTIVE —Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San Antonio (SA-NHW). However, the higher prevalence of type 2 diabetes in Mexican-origin populations might be related, in part, not to Native American genetic admixture but to Spanish genetic admixture. RESEARCH DESIGN AND METHODS —Four population-based epidemiological surveys conducted with Mexican-origin and European-origin samples provided data relevant to this question. In all four surveys, type 2 diabetes was defined as fasting plasma glucose ≥7.0 mmol/l or 2-h glucose ≥11.1 mmol/l or use of antidiabetic agents. RESULTS —A comparison of the two Mexican-origin populations showed that the age- and sex-adjusted prevalence of type 2 diabetes was lower in Mexico than in SA-MA (15.1 vs. 17.9%, P = 0.032). Between the two European-origin populations, the prevalence of type 2 diabetes was lower in SA-NHW than in Spain (6.2 vs. 9.1%, P < 0.0001), but differences were attenuated by adjustment for BMI or after stratification by education. In logistic regression analyses, type 2 diabetes was associated with Mexican ethnic origin after adjusting for age, education, BMI, and waist-to-hip ratio. CONCLUSIONS —The prevalence of type 2 diabetes in Spain was intermediate between that in Mexican-origin populations and SA-NHW. Although the higher degree of Native American admixture is a major contributor to the higher rates of type 2 diabetes, we cannot completely rule out a partial contribution of Spanish admixture to diabetes susceptibility among Mexican- origin populations. MCDS, Mexico City Diabetes Study OR, odds ratio SAHS, San Antonio Heart Study SA-NHW, non-Hispanic whites in San Antonio SA-MA, Mexican-Americans in San Antonio SIRS, Spanish Insulin Resistance Study WHR, waist-to-hip ratio Footnotes Address correspondence and reprint requests to Carlos Lorenzo, MD, Department of Medicine, Division of Clinical Epidemiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873. E-mail: lorenzo{at}uthscsa.edu . Received for publication 4 May 2001 and accepted in revised form 4 September 2001. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.
Author Maria T. Martinez-Larrad
Carlos Lorenzo
Clicerio Gonzalez-Villalpando
Michel P. Stern
Helen P. Hazuda
Ken Williams
Steven M. Haffner
Manel Serrano-Rios
Rafael Gabriel
Author_xml – sequence: 1
  fullname: Carlos Lorenzo
– sequence: 2
  fullname: Manel Serrano-Rios
– sequence: 3
  fullname: Maria T. Martinez-Larrad
– sequence: 4
  fullname: Rafael Gabriel
– sequence: 5
  fullname: Ken Williams
– sequence: 6
  fullname: Clicerio Gonzalez-Villalpando
– sequence: 7
  fullname: Michel P. Stern
– sequence: 8
  fullname: Helen P. Hazuda
– sequence: 9
  fullname: Steven M. Haffner
BookMark eNptkM1OwzAQhC1URH_gBTj5jhJsx2njE0IFWqSiRlDEMXKcTWsU7MhOgT4Ob0pCc-S0Wu3Mp50Zo4GxBhC6pCRkUTS7LrRU0kHIeEhZyEgsTtCIiigO4pgnAzQilIsgFoIN0dj7d0II50lyhoaUzlhEkmiEft6kx80O8FL7xjqt8Nyaxul832hrsC3xSy21wY39Uz3Bt1bS4AUYwKm1FU6la7SsqgN-Bl9b43VeAS6t66nbHTicOviUFRgFHXFzqAEzfKdlDg143OJ7brB2etuuqa33lew-8Dfn6LSUlYeLfk7Q68P9Zr4MVuvF4_x2FSjGiQiAcpWD4kLxSLAZK0AoksQ5JVNWiGmcC2B5XCZT4JLP2vAFLdhUqqhMBCRcRBPEjlzlrPcOyqx2-kO6Q0ZJ1vWd9X1njGeUZV3frenqaNq1Qb90eyz6VP-pfwFzAYZP
CitedBy_id crossref_primary_10_1157_13080210
crossref_primary_10_1007_s00439_010_0803_x
crossref_primary_10_1016_S0025_7753_03_73614_8
crossref_primary_10_2337_db06_0905
crossref_primary_10_1016_j_rceng_2021_06_002
crossref_primary_10_1016_S0188_4409_03_00069_9
crossref_primary_10_1016_j_rce_2021_06_002
crossref_primary_10_1186_s12889_020_8378_5
crossref_primary_10_1038_oby_2003_198
crossref_primary_10_1097_00004872_200308000_00009
crossref_primary_10_1111_j_1464_5491_2012_03723_x
crossref_primary_10_1111_j_1464_5491_2005_01739_x
crossref_primary_10_1007_s11892_005_0012_5
crossref_primary_10_1177_0898264307309924
crossref_primary_10_1016_j_ecl_2004_03_005
crossref_primary_10_1016_j_gene_2013_03_024
crossref_primary_10_1089_met_2006_4_1
crossref_primary_10_1161_HYPERTENSIONAHA_107_096263
crossref_primary_10_1157_13109554
crossref_primary_10_1016_j_socscimed_2004_11_040
crossref_primary_10_1016_S1262_3636_07_70125_8
crossref_primary_10_1016_j_amjmed_2011_07_019
crossref_primary_10_1016_j_amjmed_2011_07_018
crossref_primary_10_1016_j_arcmed_2005_01_006
crossref_primary_10_1016_j_gene_2015_03_065
crossref_primary_10_1093_hmg_ddq173
crossref_primary_10_2337_db07_0482
crossref_primary_10_1002_dmrr_244
crossref_primary_10_1157_13127917
crossref_primary_10_1186_1471_2164_11_326
crossref_primary_10_1007_s10549_011_1546_7
crossref_primary_10_2337_diacare_26_1_61
crossref_primary_10_4158_EP_13_1_77
crossref_primary_10_1186_1471_2350_11_148
crossref_primary_10_1002_dmrr_3097
crossref_primary_10_1038_oby_2003_86
crossref_primary_10_1007_s00439_003_0912_x
crossref_primary_10_1177_1474651403003001S0201
crossref_primary_10_1111_acer_13576
crossref_primary_10_18705_1607_419X_2007_13_2_95_112
crossref_primary_10_1371_journal_pone_0019327
crossref_primary_10_1038_s41598_019_39145_x
crossref_primary_10_1046_j_1365_2265_2003_01871_x
crossref_primary_10_1016_j_metabol_2004_06_006
crossref_primary_10_1038_s41598_019_45389_4
crossref_primary_10_1080_19485565_2005_9989105
crossref_primary_10_1016_j_jacc_2008_12_037
crossref_primary_10_1016_j_arcmed_2020_05_010
Cites_doi 10.1002/ajpa.1330290502
10.2337/diabetes.44.12.1386
10.2337/diacare.14.2.102
10.1093/ajcn/61.4.765
10.1093/oxfordjournals.aje.a113956
10.1001/archinte.156.17.1994
10.2337/diacare.20.5.773
10.1017/S0007114500001082
10.1093/oxfordjournals.aje.a116731
10.2337/diacare.20.7.1183
10.2337/diab.33.1.86
10.2337/diab.41.4.484
10.1093/oxfordjournals.aje.a114228
10.1056/NEJM198607243150403
10.1161/01.CIR.90.3.1542
10.1016/S1047-2797(96)00026-9
10.2105/AJPH.89.5.723
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.2337/diacare.24.12.2059
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 2064
ExternalDocumentID 10_2337_diacare_24_12_2059
diacare_24_12_2059
GroupedDBID -
08R
0R
1AW
29F
2WC
3V.
4.4
41
53G
55
5B
5GY
5RE
5RS
5VS
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
AAIKC
AASXA
AAWTL
AAYEP
ABFLS
ABOCM
ABPPZ
ABPTK
ABUWG
ACGOD
ACJLH
ACVYA
ADACO
ADBBV
ADBIT
AENEX
AFDAS
AFFNX
AFKRA
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
ATCPS
AZQEC
BAWUL
BBAFP
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C1A
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
ET
EX3
F5P
FYUFA
GJ
GNUQQ
GUQSH
GX1
H13
HCIFZ
HZ
IAG
IAO
IEA
IGG
IHR
INH
INR
IOF
IPO
ITC
J5H
K9-
KM
KQ8
L7B
M0K
M0R
M0T
M1P
M2O
M2P
M2Q
M5
MBDVC
O0-
O9-
OK1
OVD
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
Q2X
RHF
RHI
S0X
SJFOW
SV3
TDI
TWZ
WH7
WOQ
WOW
X7M
XZ
ZA5
ZGI
ZXP
---
-ET
..I
.55
.GJ
.XZ
08P
0R~
18M
41~
6PF
AAKAS
AAMNW
AAYXX
ACGFO
ADZCM
AEGXH
AERZD
AFOSN
AIAGR
ALIPV
BTFSW
CCPQU
CITATION
EMOBN
HMCUK
HZ~
M5~
N4W
NAPCQ
TEORI
TR2
UKHRP
VVN
W8F
WHG
YHG
YOC
~KM
ID FETCH-LOGICAL-c2409-e14cbec49c439272de9c085b1062d965b9e2b5f86e4a47308d1d26ac3f89e8493
ISSN 0149-5992
IngestDate Fri Aug 23 01:52:49 EDT 2024
Fri Jan 15 19:48:12 EST 2021
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2409-e14cbec49c439272de9c085b1062d965b9e2b5f86e4a47308d1d26ac3f89e8493
OpenAccessLink https://diabetesjournals.org/care/article-pdf/24/12/2059/587520/dc1201002059.pdf
PMID 11723083
PageCount 6
ParticipantIDs highwire_diabetes_diacare_24_12_2059
crossref_primary_10_2337_diacare_24_12_2059
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20011201
PublicationDateYYYYMMDD 2001-12-01
PublicationDate_xml – month: 12
  year: 2001
  text: 20011201
  day: 01
PublicationDecade 2000
PublicationTitle Diabetes care
PublicationYear 2001
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References 2022031213255934800_R7
2022031213255934800_R8
2022031213255934800_R9
2022031213255934800_R3
2022031213255934800_R11
2022031213255934800_R22
2022031213255934800_R4
2022031213255934800_R10
2022031213255934800_R21
2022031213255934800_R5
2022031213255934800_R20
2022031213255934800_R6
2022031213255934800_R1
2022031213255934800_R2
2022031213255934800_R19
2022031213255934800_R18
2022031213255934800_R17
2022031213255934800_R16
2022031213255934800_R15
2022031213255934800_R14
2022031213255934800_R13
2022031213255934800_R24
2022031213255934800_R12
2022031213255934800_R23
References_xml – ident: 2022031213255934800_R2
  doi: 10.1002/ajpa.1330290502
– ident: 2022031213255934800_R9
  doi: 10.2337/diabetes.44.12.1386
– ident: 2022031213255934800_R10
  doi: 10.2337/diacare.14.2.102
– ident: 2022031213255934800_R23
  doi: 10.1093/ajcn/61.4.765
– ident: 2022031213255934800_R4
  doi: 10.1093/oxfordjournals.aje.a113956
– ident: 2022031213255934800_R11
  doi: 10.1001/archinte.156.17.1994
– ident: 2022031213255934800_R19
– ident: 2022031213255934800_R12
  doi: 10.2337/diacare.20.5.773
– ident: 2022031213255934800_R16
– ident: 2022031213255934800_R17
– ident: 2022031213255934800_R24
  doi: 10.1017/S0007114500001082
– ident: 2022031213255934800_R15
– ident: 2022031213255934800_R14
– ident: 2022031213255934800_R22
  doi: 10.1093/oxfordjournals.aje.a116731
– ident: 2022031213255934800_R18
  doi: 10.2337/diacare.20.7.1183
– ident: 2022031213255934800_R20
– ident: 2022031213255934800_R1
  doi: 10.2337/diab.33.1.86
– ident: 2022031213255934800_R5
  doi: 10.2337/diab.41.4.484
– ident: 2022031213255934800_R7
  doi: 10.1093/oxfordjournals.aje.a114228
– ident: 2022031213255934800_R8
  doi: 10.1056/NEJM198607243150403
– ident: 2022031213255934800_R13
  doi: 10.1161/01.CIR.90.3.1542
– ident: 2022031213255934800_R3
  doi: 10.1016/S1047-2797(96)00026-9
– ident: 2022031213255934800_R21
– ident: 2022031213255934800_R6
  doi: 10.2105/AJPH.89.5.723
SSID ssj0004488
Score 1.9746749
Snippet Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin...
OBJECTIVE—Mexican-American populations in San Antonio, Texas (SA-MA) and Mexico have a higher prevalence of type 2 diabetes than non-Hispanic whites in San...
SourceID crossref
highwire
SourceType Aggregation Database
Publisher
StartPage 2059
Title Was the Historic Contribution of Spain to the Mexican Gene Pool Partially Responsible for the Higher Prevalence of Type 2 Diabetes in Mexican-Origin Populations?
URI http://care.diabetesjournals.org/content/24/12/2059.abstract
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZZB2MvY1fWdRt66FtQFsuXWE9jdBtlLFspKeubkWQJAsEuaQoj_2Z_rb9k5-hiu1kH615MYuQPx-fz0TnKd44IOcy0ytIik8xYO2OZtZJBFF4Al5XSEJGnqXYq32_F8Vn25Tw_H42uB6qlq42a6O2tdSX_Y1U4B3bFKtk7WLYDhRPwGewLR7AwHP_Jxj_kpQscY68PrN_rdrBy5SgXEnWMPrycm5_O52Gn6fEJ9t48QUy5WmEcHqSyK9MJD4MEBJs8SVeahIgLv2T7MS7ZLpuIy767PbYAOW4JdrmjGuwuQrlZpwRq16bZtkF8smq7GB-8GMyjLTtdeiXgXDamFzG67gdmy75KGFWHqqOlHC8mnaJIqvXSaxBOpY2lAXGBIxmIReKap2C58FvmTYz30yLNGURC5dCR-2LsSFg-dMvT0HbchK--c_ru9MFT14AAXkx8DhOe4Upxf-2wV_fOHNopGyGnQpQqYFQ8qxJeIcY9cp_PRI6y0_KolyFBelx6ma3_kb6wCzHe_XkfN4On2NB6EBAtHpNHIZOhHzwtn5CRaZ6SB_Og1XhGfgE7KfCIRnbSITtpa6ljJ920blRgEUV2UmQn7dhJB-ykwM6AiuykPTsREdlJOY1EowB_k510wM73z8nZ50-Lo2MWNgRhGgJPwUwCrsXoTGgIo_mM10ZoSBlUMi14LYpcCcNVbsvCZDKDqausk5oXUqe2FKYEx_OC7DVtY14SWkBmrnJdiKKegYeyJa8ht7C1FhYymGm9T8bxSVcXvu9L9Xfb7pPDaIwq_mdyy7BXdwI9IA_71-E12dusr8wbiIA36q2j0G9o-rVz
link.rule.ids 315,786,790,27955,27956
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Was+the+Historic+Contribution+of+Spain+to+the+Mexican+Gene+Pool+Partially+Responsible+for+the+Higher+Prevalence+of+Type+2+Diabetes+in+Mexican-Origin+Populations%3F&rft.jtitle=Diabetes+care&rft.au=Lorenzo%2C+Carlos&rft.au=Serrano-Rios%2C+Manel&rft.au=Martinez-Larrad%2C+Maria+T.&rft.au=Gabriel%2C+Rafael&rft.date=2001-12-01&rft.issn=0149-5992&rft.eissn=1935-5548&rft.volume=24&rft.issue=12&rft.spage=2059&rft.epage=2064&rft_id=info:doi/10.2337%2Fdiacare.24.12.2059&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_diacare_24_12_2059
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon